Abstract
COVID-19 pandemic results in record high deaths in many countries. Although a vaccine for SARS-CoV-2 is now available, effective antiviral drugs to treat coronavirus diseases are not available yet. Recently, EGCG, a green tea polyphenol, was reported to inhibit SARS-CoV-2 3CL-protease, however the effect of EGCG on coronavirus replication is unknown. In this report, human coronavirus HCoV-OC43 (beta coronavirus) and HCoV-229E (alpha coronavirus) were used to examine the effect of EGCG on coronavirus. EGCG treatment decreases 3CL-protease activity of HCoV-OC43 and HCoV-229E. Moreover, EGCG treatment decreased HCoV-OC43-induced cytotoxicity. Finally, we found that EGCG treatment decreased the levels of coronavirus RNA and protein in infected cell media. These results indicate that EGCG inhibits coronavirus replication.
Original language | English |
---|---|
Pages (from-to) | 23-28 |
Number of pages | 6 |
Journal | Biochemical and Biophysical Research Communications |
Volume | 547 |
DOIs | |
Publication status | Published - 2021 Apr 2 |
Bibliographical note
Funding Information:This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government ( 2019R1A2C1006511 ).
Publisher Copyright:
© 2021 Elsevier Inc.
All Science Journal Classification (ASJC) codes
- Biophysics
- Biochemistry
- Molecular Biology
- Cell Biology